Onderneming Orchard Therapeutics plc
Aandelen
ORTX
US68570P2002
Farmaceutische producten
Vakgebied
Aantal werknemers: 166
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bobby Gaspar
CEO | Chief Executive Officer | 60 | 01-01-15 |
Frank Thomas
PSD | President | 54 | 01-01-18 |
Leslie Meltzer
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-18 |
Nicoletta Loggia
CTO | Chief Tech/Sci/R&D Officer | 56 | 09-09-21 |
Fulvio Mavilio
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
Renee T. Leck
IRC | Investor Relations Contact | - | - |
Christopher York
SEC | Corporate Secretary | - | - |
Braden Parker
PRN | Corporate Officer/Principal | - | - |
John Cerio
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Abdul Mullick
BRD | Director/Board Member | - | 24/01 |
Yasuo Fujii
BRD | Director/Board Member | - | 24/01 |
60 | - | ||
Director/Board Member | 62 | 24/01 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 126 572 749 | 81 786 701 ( 64,62 %) | 0 | 64,62 % |
Bedrijfsgegevens
Orchard Therapeutics Plc
245 Hammersmith Road 3rd Floor
W6 8PW, London
+44 20 3 808 8286
http://www.orchard-tx.com![Adres Orchard Therapeutics plc(ORTX)](https://cdn.zonebourse.com/static/address/46901491.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,01% | 811 mld. | |
+43,90% | 640 mld. | |
-6,14% | 353 mld. | |
+19,50% | 333 mld. | |
+10,15% | 302 mld. | |
+17,45% | 246 mld. | |
+2,41% | 225 mld. | |
+12,81% | 218 mld. | |
+9,37% | 168 mld. |